Mertk, CPTAC-3409 - CPTAC Assay Portal (original) (raw)
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.
Protein Sequence hover to view complete sequence
| 10 | 20 | 30 | 40 | 50 |
|---|---|---|---|---|
| MVLAPLLLGL | LLLPALWSGG | TAEKWEETEL | DQLFSGPLPG | RLPVNHRPFS |
| 60 | 70 | 80 | 90 | 100 |
| APHSSRDQLP | PPQTGRSHPA | HTAAPQVTST | ASKLLPPVAF | NHTIGHIVLS |
| 110 | 120 | 130 | 140 | 150 |
| EHKNVKFNCS | INIPNTYQET | AGISWWKDGK | ELLGAHHSIT | QFYPDEEGVS |
| 160 | 170 | 180 | 190 | 200 |
| IIALFSIASV | QRSDNGSYFC | KMKVNNREIV | SDPIYVEVQG | LPYFIKQPES |
| 210 | 220 | 230 | 240 | 250 |
| VNVTRNTAFN | LTCQAVGPPE | PVNIFWVQNS | SRVNEKPERS | PSVLTVPGLT |
| 260 | 270 | 280 | 290 | 300 |
| ETAVFSCEAH | NDKGLTVSKG | VHINIKVIPS | PPTEVHILNS | TAHSILVSWV |
| 310 | 320 | 330 | 340 | 350 |
| PGFDGYSPLQ | NCSIQVKEAD | RLSNGSVMVF | NTSASPHLYE | IQQLQALANY |
| 360 | 370 | 380 | 390 | 400 |
| SIAVSCRNEI | GWSAVSPWIL | ASTTEGAPSV | APLNITVFLN | ESNNILDIRW |
| 410 | 420 | 430 | 440 | 450 |
| TKPPIKRQDG | ELVGYRISHV | WESAGTYKEL | SEEVSQNGSW | AQIPVQIHNA |
| 460 | 470 | 480 | 490 | 500 |
| TCTVRIAAIT | KGGIGPFSEP | VNIIIPEHSK | VDYAPSSTPA | PGNTDSMFII |
| 510 | 520 | 530 | 540 | 550 |
| LGCFCGFILI | GLILCISLAL | RRRVQETKFG | GAFSEEDSQL | VVNYRAKKSF |
| 560 | 570 | 580 | 590 | 600 |
| CRRAIELTLQ | SLGVSEELQN | KLEDVVIDRN | LLVLGKVLGE | GEFGSVMEGN |
| 610 | 620 | 630 | 640 | 650 |
| LKQEDGTSQK | VAVKTMKLDN | FSQREIEEFL | SEAACMKDFN | HPNVIRLLGV |
| 660 | 670 | 680 | 690 | 700 |
| CIELSSQGIP | KPMVILPFMK | YGDLHTFLLY | SRLNTGPKYI | HLQTLLKFMM |
| 710 | 720 | 730 | 740 | 750 |
| DIAQGMEYLS | NRNFLHRDLA | ARNCMLRDDM | TVCVADFGLS | KKIYSGDYYR |
| 760 | 770 | 780 | 790 | 800 |
| QGRIAKMPVK | WIAIESLADR | VYTSKSDVWA | FGVTMWEITT | RGMTPYPGVQ |
| 810 | 820 | 830 | 840 | 850 |
| NHEMYDYLLH | GHRLKQPEDC | LDELYDIMYS | CWSADPLDRP | TFSVLRLQLE |
| 860 | 870 | 880 | 890 | 900 |
| KLSESLPDAQ | DKESIIYINT | QLLESCEGIA | NGPSLTGLDM | NIDPDSIIAS |
| 910 | 920 | 930 | 940 | 950 |
| CTPGAAVSVV | TAEVHENNLR | EERYILNGGN | EEWEDVSSTP | FAAVTPEKDG |
| 960 | 970 | 980 | 990 | 994 |
| VLPEDRLTKN | GVSWSHHSTL | PLGSPSPDEL | LFVDDSLEDS | EVLM |
Data source: UniProt
Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs
Uniprot Database Entry PhosphoSitePlus ®
Click a point on a node
to view detailed assay information below
All other points link out to UniProt
Phosphorylation Acetylation Ubiquitylation Other
loading
Assay Details for non-CPTAC-3409 Collapse assay details
Data source: Panorama
Official Gene Symbol
Mertk
Peptide Sequence
SHPAHTAAPQVTSTASK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
67
Peptide End
83
CPTAC ID
non-CPTAC-3409
Peptide Molecular Mass
1,689.8434
Species
Mus musculus (Mouse)
Assay Type
Direct MRM
Matrix
Plasma
Submitting Laboratory
UVic-Genome BC Proteomics Centre
Submitting Lab PI
Christoph Borchers
Publication
View Details (opens in a new window)
Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays. Michaud SA, Sinclair NJ, Petrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y Eshghi A1, Richard VR, Sickmann A, Borchers CH. Commun Biol. 2018 Jun 27;1:78. doi: 10.1038/s42003-018-0087-6. eCollection 2018.
Assay Parameters Collapse assay parameters
Data source: Panorama
Instrument
Agilent 6490/6495 QQQ
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
1290 LC (Agilent)
Column Packing
Zorbax Eclipse Plus C18, 1.8 µm
Column Dimensions
2.1 x 150 mm
Flow Rate
400 µL/min
Chromatograms
Data source: Panorama
Response Curves
Data source: Panorama
Retrieving Data
Repeatability
Data source: Panorama
| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CV
| n= | | | | | | | | | |
| ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- |
| Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
| b8 (2+) | 13.6 | 8 | 5.8 | 13.9 | 9.3 | 10.6 | 19.4 | 12.3 | 12.1 | 15 | 15 | 15 |
| b7 (2+) | 19 | 11.1 | 6.4 | 24.4 | 9.3 | 7.5 | 30.9 | 14.5 | 9.9 | 15 | 15 | 15 |
| b2 (1+) | 19 | 5 | 6.9 | 22 | 7.2 | 8.7 | 29.1 | 8.8 | 11.1 | 15 | 15 | 15 |
| y9 (2+) | 16.7 | 8.7 | 5.3 | 17.8 | 10.9 | 11.4 | 24.4 | 13.9 | 12.6 | 15 | 15 | 15 |
| y15 (2+) | 12.1 | 10.2 | 7.4 | 16.8 | 8.7 | 8.9 | 20.7 | 13.4 | 11.6 | 15 | 15 | 15 |
| sum | 7.5 | 3 | 3.3 | 9.1 | 3.4 | 7.6 | 11.8 | 4.5 | 8.3 | 15 | 15 | 15 |